Avalanche Biotechnologies Announces Closing of Initial Public Offering and Exercise o…

Exercise

MENLO PARK, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) — Avalanche Biotechnologies, Inc., a clinical-stage biotechnology company focused on …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave